Our turn has arrived

After watching many stocks climb, while ours has floundered and fell, its a good feeling to finally be on the home run.

10 years plus of work and negotiations will start to materialize in licenses, royalty income, and products.

2016 will be the year that many of us thought (including OBJ management) last year was meant to be.

Once the momentum starts it will be a nice ride, for the faithful that have no lost nerve and sold.

Biotech is the flavour, and with our partnerships, we are in a strong position to capitalize.

Its just the beginning of a long awaited re rate..

Enjoy, we have been waiting long enough for it..